ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 109

Comparison Of Characteristics In Rheumatoid Arthritis Between International and National Databases In Europe: A Systematic Literature Review

E. Gvozdenovic1, R. Koevoets1, J. Langenhoff2, C.F. Allaart1 and R. Landewe3, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Outcome measures, registries and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services I

Session Type: Abstract Submissions (ACR)

Background/Purpose: RA (Rheumatoid Arthritis) cohorts and registers are established for daily practice in clinical care. There are still differences between registries in disease activity and outcome, despite existing guidelines and international consensus about preferred drug therapies, which might be due to varying definitions for disease, inclusion criteria and variety in usage of biological agents. To improve collaboration between European rheumatologists, EULAR (European League Against Rheumatism) has recently started a repository of databases, which can be used as a platform for researchers to start collaborative projects. Our aim is to evaluate current European inter (national) databases and observational cohorts, and to compare inclusion criteria, aims, collected data and participation in the EULAR repository of databases.

Methods: An extensive search strategy was performed in Pubmed, Web of Science (WOS), Embase, Academic Search Premier, Wiley-Blackwell and LWW. Articles reporting on European inter (national) databases and prospective cohorts in RA with at least half a year of follow-up and >200 patients included were selected. We extracted data on national and international databases with details on aim, size, selection criteria, year of inception, frequency of data collection, physician/clinical evaluation, patient reported outcomes, laboratory information, funding and rheumatologic diseases captured.

Results: In total, 418 articles were included, which described 4 international and 39 national databases and cohorts. International databases were roughly similar and are mostly initiated to monitor and compare clinical patient care among countries. Also no restriction was present in frequency of data collection and selection criteria. The national databases differ in clinical features, such as aims (most registers aimed at efficacy and safety of treatment or monitoring disease activity in clinical practice), distribution among countries (not evenly distributed) and inclusion criteria (e.g. early RA registers versus routine care registers). Half of the national registers were connected to the EULAR repository of databases.

Conclusion: International databases have similar characteristics and the patients represent a large range of clinical activity (from inactive to active) and severity (from mild to severe). Regarding the national databases and cohorts heterogeneity is far greater, relevant differences exist in inclusion criteria, aims, frequency of data collection and distribution among Europe. Also only half of the databases are connected to the EULAR repository of databases. These differences may indicate that among researchers there is little awareness in guidelines to set up registers or cohorts and in the existence of the collaboration network of the EULAR.


Disclosure:

E. Gvozdenovic,
None;

R. Koevoets,
None;

J. Langenhoff,
None;

C. F. Allaart,
None;

R. Landewe,

Pfizer, Janssen, Merck, Abbott,

2,

Pfizer, Janssen, Merck, Abbott, Amgen, Astra, BMS, Centocor, GSK, UCS, Vertex,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-characteristics-in-rheumatoid-arthritis-between-international-and-national-databases-in-europe-a-systematic-literature-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology